Status | Study |
Recruiting |
Study Name: The Clinical Study on Treating Acute Gouty Arthritis Using Both Internal and External Therapy of Tonifying Spleen and Descending Turbid Condition: Acute Gouty Arthritis Date: 2015-09-02 Interventions: Drug: diclofenac sodium enteric-coated Dru |
Completed |
Study Name: Phase 2a RDEA3170 and Allopurinol Combination Study in Gout Subjects Condition: Gout Date: 2015-07-13 Interventions: Drug: RDEA3170 2.5 mg |
Active, not recruiting |
Study Name: Intensive Urate Lowering Therapy of Febuxostat Compared to Allopurinol on Cardiovascular Risk in Patients With Gout Condition: Gout Date: 2015-07-07 Interventions: Drug: Febuxostat 80/120mg/day |
Recruiting |
Study Name: Elastography as Gouty Arthropathy Outcome (EGO) Condition: Gout Date: 2015-06-11 |
Completed |
Study Name: DECT Study in Allopurinol-Treated Gout Patients Condition: Gout Date: 2015-03-15 Interventions: Procedure: DECT scan |
Completed |
Study Name: Bucillamine for the Treatment of Acute Gout Flare in Subjects With Moderate to Severe Gout Condition: Gout Date: 2014-12-31 Interventions: Drug: Bucillamine Bucillamine |
Completed |
Study Name: A PD/Safety Study of RDEA3170 in Combination With Febuxostat for Treating Gout or Asymptomatic Hyperuricemia Patients Condition: Gout and Asymptomatic Hyperuricemia Date: 2014-12-09 Interventions: Drug: RDEA3170 Oral Treatment |
Completed |
Study Name: Phase 2 Study of URC102 to Assess the Efficacy and Safety in Gout Patients Condition: Gout Hyperuricemia Date: 2014-11-04 Interventions: Drug: URC102 0.25mg Drug: URC102 0.5mg |
Completed |
Study Name: RDEA3170 and Allopurinol Combination Study in Gout Subjects Condition: Gout Date: 2014-10-28 Interventions: Drug: RDEA3170 10 mg Drug: allopurinol 300 |
Active, not recruiting |
Study Name: Open-Label Study of Uridine Triacetate in Pediatric Patients With Hereditary Orotic Aciduria Condition: Hereditary Orotic Aciduria Date: 2014-04-01 Interventions: Drug: uridine triacetate Other Names: PN401 (Company Code Name) |